BRAF and colorectal carcinoma: For colorectal carcinoma, NTRK fusions are typically mutually exclusive of other mutations, thus the ideal scenario includes reflexive NTRK testing via NGS in all RAS/BRAF V600E wild-type, microsatellite instability (MSI)-high and mismatch repair deficient (dMMR) [53].